Aspire BioScience (“AspireBio”) is a wholly owned subsidiary of Exxel Pharma, Inc. The Company is focused on development its two lead therapeutics, URB937 and URB597, which were developed at the University of California, Irvine (UCI). Both molecules modulate natural endocannabinoid signaling, and have significant, transformative clinical and commercial potential in diseases with substantial unmet medical needs.
Company Details
- Employees
- 1
- Founded
- -
- Address
- Boulder, Boulder,co 80302,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- aspirebioscience.com
- Keywords
- Therapeutics.
- HQ
- Boulder, CO
Aspire Bioscience Questions
Aspire Bioscience's website is aspirebioscience.com
Aspire Bioscience's LinkedIn profile is https://www.linkedin.com/company/aspire-bioscience-llc
Aspire Bioscience has
1 employees.
View email and phone details for 1
employees at Aspire Bioscience.
Aspire Bioscience's industry is
Pharmaceutical Manufacturing
Aspire Bioscience's top competitors are
Accelerating Research & Development For Advanced Therapies (Ardat),
Dot Clue,
Ad Instruments Sl,
Microa,
Apollo Sciences,
Nanoptima Limited,
Biozen Limited,
Aspire Biologics,
Rexil Agro,
Aspire Biosciences.
Aspire Bioscience's categories are Pharmaceutical Manufacturing
Aspire Bioscience's founding year is 2016
